IPPI: The IP Policy Institute

IPPI 2026 Spring Progress Report (December 2025- February 2026) Navigation Greetings from IPPI Research Professor & Executive Director Joshua Kresh We’ve had both a productive end to 2025 and start to 2026. IPPI hosted our final meeting of the 2025-2026 Edison Fellowship in January, and Fellows are starting to submit papers for publication. We also accepted our next round of Fellows, gathered for…

IPPI 2025 Winter Progress Report (September – November 2025) Navigation Greetings from IPPI Research Professor & Executive Director Joshua Kresh We have had a busy fall and have no plans on slowing down next year. November brought our inaugural roundtable on Intellectual Property and Biopharma Policy in Washington, D.C. (see this report for more details), followed by our IP and High-Tech roundtab…

By Kristen Osenga Cross-posted with permission from Professor Osenga’s December 8, 2025, Cross-posted with permission from Professor Osenga’s December 8, 2025,

IPPI Fall 2025 Progress Report (June – August 2025) Navigation Greetings from IPPI Research Professor & Executive Director Joshua Kresh I am happy to report a productive summer quarter marked by significant milestones and successful new initiatives that have strengthened our institute’s global research network and educational impact. In June, we launched the WIPO-U.S. Summer School on IP in partn…

By Michael Doane The CEO of a small technology-based company with many groundbreaking patents in its field once asked me what the point was of obtaining patents when the company simply did not have the resources to enforce them. Although patents provide many benefits, the ability to enforce them against infringers is paramount. Patent infringement litigation is euphemistically referred to as “The…

IPPI Spring 2025 Progress Report (March – May 2025) Navigation Greetings from IPPI Research Professor & Executive Director Joshua Kresh We are pleased to present our first comprehensive progress report since IPPI’s launch at The University of Akron on March 1st. Team Transition and Growth: Our transition from George Mason University has been highly successful. The vast majority of our Scholars, F…

IPPI has submitted formal comments to the U.S. Department of Commerce regarding its Section 232 investigation of pharmaceutical imports, cautioning against imposing tariffs on medicines and their ingredients. In our submission, IPPI scholars Mark Schultz, Emily Michiko Morris, and Joshua Kresh explain that imposing such tariffs would have severe negative consequences for American patients, health…

By Kristen Jakobsen Osenga As the 118th Congress drew to a close at the end of 2024, there was a spate of intellectual property activity on Capitol Hill. I was fortunate enough to be part of one of these exciting events. On December 18, 2024, the IP Subcommittee of the Senate Judiciary Committee held a hearing on the RESTORE Patent Rights Act. I was one of four witnesses testifying at that hearin…

Navigation - Announcing IPPI: The IP Policy Institute - IPPI Spring Progress Report (December 2024-February 2025) Announcing IPPI: The IP Policy Institute A Message from Faculty Chair Mark Schultz and Executive Director Joshua Kresh Dear Friends of the Innovation and Creative Industries, We’re excited to announce the launch of IPPI: The IP Policy Institute at The University of Akron School of Law…

Greetings from C-IP2 Interim Executive Director Joshua A. Kresh Reflecting on this vibrant winter season at the Center for Intellectual Property x Innovation Policy, I am filled with gratitude and excitement. As you can read in the report linked below, which covers this past September through November, we have been active and productive, hosting public and private events and supporting academic w…

By Keith Mallinson It was my pleasure to participate in a panel session on “SEP Current & Proposed Regulations” last month at the George Mason University Antonin Scalia Law School Center for Intellectual Property x Innovation Policy (C-IP2) Annual Fall Conference entitled “The Importance of Exclusive Rights.” The other panelists were Angela Barr, Mark Cohen, […]

By Kristen Osenga I recently had the pleasure of participating in a panel on third-party litigation funding (TPLF), which was part of the Annual Fall Conference at George Mason University’s Center for Intellectual Property x Innovation Policy. The panel included experts from both industry and academia, highlighted the growing debate around TPLF, and crystallized why […]

By Emily Michiko Morris & Douglas Park The high cost of some pharmaceuticals is a complex issue, but the Federal Trade Commission’s (FTC’s) most recent criticism of pharmaceutical patents’ role is misguided. The FTC has criticized the listing of drug product device patents in the FDA’s “Orange Book,” a listing of patents related to various […]

CIP2 congratulates the Arts & Entertainment Advocacy Clinic at Scalia Law, led by Professor Sandra Aistars, and Student Advocate Natalie Nachman, and supported by Counsel of Record Matt Hersh of Mestaz Law, for filing a powerful amicus brief on behalf of three Tattoo Artists in the 9th Circuit Court of Appeals this week in Sedlik […]

Greetings from C-IP2 Interim Executive Director Joshua A. Kresh As we transition into the fall season, I am delighted to share that we have had a productive summer and are looking forward to an eventful fall and winter. The past months have been marked by significant achievements and exciting developments, building upon the robust foundation […]

The following post was originally published on the Patently-O blog and is cross-posted here with permission from both Patently-O and the author. Senators aim to rein in digital replicas with the “NO FAKES” Act which proposes a limited federal right to control one’s likeness using some DMCA-like notice-and-takedown elements. Guest post by Professor Justin Hughes […]

By Molly Stech* * The blog post below and the law review article it links to are the individual thoughts and views of the author and should not be attributed to any entity with which she is currently or has been affiliated. Despite a recent decision from the Beijing Internet Court, there is growing consensus […]

Greetings from C-IP2 Interim Executive Director Joshua A. Kresh I am pleased to report that we have had a productive spring and are working on several items for this summer and fall. Since our last report, we published several policy briefs on pending legislation, held our launch event for our 5G book, welcomed our new […]

By Emily Michiko Morris and Joshua Kresh Executive summary: Many critics of pharmaceutical companies argue that they abuse the patent system through “evergreening” or “thickets” to increase the amount of time they can avoid generic competition and keep drug prices high. Those critics have not looked at the real-world effects of pharmaceutical patents on generic […]

The following post comes from Jack Ring, a 3L at Scalia Law and a Research Assistant at C-IP2.  On April 15, 2024, C-IP2 scholars and contributors to 5G and Beyond: Intellectual Property and Competition Policy in the Internet of Things met for a live-streamed book launch event.[2] Professor Jonathan Barnett, one of the books two […]